(Page 7)

May 16, 2024 New Health Blueprint Maps Healthier Future for Southwest Virginia

A new plan outlines solutions to the grave health problems that grip a rural region beset by a lack of care access.

May 6, 2024 Late Scientist’s Last Works Could Spur New Cancer Treatments

Years after his death, John Herr's research has opened the door for new treatments for solid tumors, including breast cancer and melanoma.

April 25, 2024 New Tool to Boost Battle Against Childhood Undernutrition

Childhood undernutrition contributes to almost half of all deaths of children under 5.

April 18, 2024 SHINE Trial Sheds Light on Deadly Stroke Complication

A nationwide trial led by UVA Health provides answers on how best to manage stroke patients' blood sugar after clot-busting treatment.

April 15, 2024 Artificial Intelligence Tool to Improve Heart Failure Care

The tool harnesses machine learning and artificial intelligence to determine a patient's risk of unfavorable heart failure outcomes.

April 8, 2024 Top Nanotechnology Expert to Lead UVA’s NanoSTAR Institute

Evan A. Scott, PhD, comes to UVA from Northwestern University, where he has conducted groundbreaking nanotechnology research.

April 8, 2024 Elias Named to Modern Healthcare’s 2024 Innovators List

UVA neurosurgeon W. Jeffrey Elias, MD, has been recognized by a leading healthcare publication as one of its Innovators for 2024.

April 3, 2024 New Plan Seeks to Improve Cancer Prevention, Clinical Trial Access

Two UVA Health experts have identified simple steps to improve cancer prevention for millions of rural and medically underserved Americans, as well as increase access to clinical trials that are the proving grounds for cutting-edge treatments.

March 28, 2024 New Advance Against a Form of Heart Failure Prevalent in Men

School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.

March 27, 2024 Enhanced Melanoma Vaccine Offers Improved Survival

Interestingly, the benefit of the second-generation melanoma vaccine was greater for male patients than female patients.